Decisive Action Needed: NMC Mandates Safe Injection Practices

The National Medical Commission (NMC) highlights the urgency to enforce safe injection practices, responding to preventable outbreaks of HIV, HBV, and HCV. The advisory demands non-reuse of single-use medical devices, emphasizing accountability and the adoption of safety-engineered syringes to prevent further public health crises.

The National Medical Commission's (NMC) recent advisory is far more than a routine compliance directive; it is a crucial intervention aimed at halting preventable outbreaks of HIV, Hepatitis B (HBV), and Hepatitis C (HCV), triggered by the unsafe reuse of syringes and other single-use medical devices. Despite longstanding WHO warnings, unsafe practices persist in India, mistakenly seen as cost-saving measures.

The NMC is firm in its directive: reuse of syringes, dialysers, or vials is strictly forbidden. The adoption of safety-engineered auto-disable syringes is essential, as these prevent reuse and protect healthcare workers from needle-stick injuries. Enforcing the Biomedical Waste Management Rules, 2016 is critical, along with regular training and audits of healthcare staff.

Industry voices, including Rajiv Nath of AiMeD, stress that the technology for safer syringes exists in India, calling for procurement that prioritizes patient safety over short-term cost-saving. The NMC's advisory, which must be seen as a binding mandate, urges immediate action to safeguard public trust and health security globally.